Verition Fund Management’s Wave Life Sciences WVE Stock Holding History

Verition Fund Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$391K	Buy	+53,895	New	+$702K	﹤0.01%	1679
2025 Q3	–	Sell	-52,728	Closed	-$343K	–	4025
2025 Q2	$343K	Sell	52,728 -102,029	-66%	-$674K	﹤0.01%	3136
2025 Q1	$1.25M	Buy	154,757 +72,874	+89%	+$797K	0.01%	1948
2024 Q4	$1.01M	Buy	+81,883	New	+$1.09M	﹤0.01%	2043
2024 Q3	–	Sell	-25,917	Closed	-$129K	–	3536
2024 Q2	$129K	Sell	25,917 -7,040	-21%	-$40.2K	﹤0.01%	2692
2024 Q1	$203K	Buy	+32,957	New	+$165K	﹤0.01%	2492
2023 Q4	–	Sell	-19,657	Closed	-$113K	–	2720
2023 Q3	$113K	Buy	+19,657	New	+$89.7K	﹤0.01%	2102
2023 Q2	–	Sell	-54,841	Closed	-$237K	–	2593
2023 Q1	$237K	Buy	+54,841	New	+$251K	﹤0.01%	1667

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Verition Fund Management's WVE Position: Q1 2026 in Review

Verition Fund Management opened a new position in Wave Life Sciences (WVE) in Q1 2026: 53,895 shares worth $391K. The stake represents ﹤0.01% of the portfolio and ranks #1679 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in WVE as recently as Q2 2025.

Verition Fund Management first reported a position in WVE in Q1 2023 and has held it in 8 quarters since. The position peaked at $1.25M in Q1 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Verition Fund Management held 53,895 shares of Wave Life Sciences worth $391K as of Q1 2026.
Wave Life Sciences was a new Verition Fund Management position in Q1 2026.
Wave Life Sciences made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #1679 holding.
Verition Fund Management first reported a position in Wave Life Sciences in Q1 2023 and has held it in 8 quarters since.
Verition Fund Management's Wave Life Sciences position peaked at $1.25M in Q1 2025.
230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.